Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 391-400 of 487 for sleep

Edit search filters
  1. A Registry For The Scientific Study Of Pulmonary Hypertension In The United States

    Jacksonville, FL

  2. Microbiome of Infectious Pleural Diseases

    Rochester, MN

  3. A Study To Evaluate Screening Biomarkers For Lung Cancer

    Jacksonville, FL

  4. A Study of Patient Reported Outcomes and Use of Self-Efficacy in the Management of Chronic Fibrotic Interstitial Lung Disease

    Rochester, MN

  5. A Study to Assess Frailty and Its Impact on Patients with Pulmonary Hypertension

    Rochester, MN

  6. Methods of Measuring Height and the Effects on Adult Predicted Lung Function

    Rochester, MN

  7. Cystic Fibrosis Patient Registry

    Rochester, MN

  8. The Impact of Cognitive Impairment on Driving Safety.

    Rochester, MN

  9. A Biorepository to Study Portopulmonary Hypertension

    Rochester, MN

  10. A Study To Evaluate DDP3 As A Predictor Of Cardiogenic Shock In Patients Presenting With Cardiac Symptoms

    Rochester, MN

.

Mayo Clinic Footer